Daniel Muthas

2.7k total citations
33 papers, 863 citations indexed

About

Daniel Muthas is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Daniel Muthas has authored 33 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Infectious Diseases. Recurrent topics in Daniel Muthas's work include Computational Drug Discovery Methods (6 papers), IL-33, ST2, and ILC Pathways (6 papers) and Cancer therapeutics and mechanisms (5 papers). Daniel Muthas is often cited by papers focused on Computational Drug Discovery Methods (6 papers), IL-33, ST2, and ILC Pathways (6 papers) and Cancer therapeutics and mechanisms (5 papers). Daniel Muthas collaborates with scholars based in Sweden, United Kingdom and United States. Daniel Muthas's co-authors include Anders Karlén, Scott Boyer, Yogesh Sabnis, Stefan Schmitt, Ruth Brenk, Aurijit Sarkar, Anna Reznichenko, Silvio Danese, Mark Berner Hansen and Mats Larhed and has published in prestigious journals such as Bioinformatics, PLoS ONE and Analytical Chemistry.

In The Last Decade

Daniel Muthas

33 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Muthas Sweden	16	305	199	181	178	93	33	863
Somesh Sharma India	22	648 2.1×	169 0.8×	233 1.3×	172 1.0×	58 0.6×	62	1.4k
Nathan A. Lack Türkiye	22	668 2.2×	124 0.6×	218 1.2×	79 0.4×	246 2.6×	55	1.4k
Tina Ritschel Netherlands	20	627 2.1×	117 0.6×	66 0.4×	223 1.3×	51 0.5×	32	1.1k
Wentao Fu United States	15	474 1.6×	127 0.6×	146 0.8×	277 1.6×	45 0.5×	25	1.4k
Erica M. Pasini Netherlands	19	426 1.4×	186 0.9×	173 1.0×	137 0.8×	52 0.6×	33	1.5k
Mark Milton United States	18	516 1.7×	73 0.4×	212 1.2×	86 0.5×	131 1.4×	36	1.2k
Daniel Vitt Germany	20	435 1.4×	168 0.8×	122 0.7×	55 0.3×	59 0.6×	45	906
Sourav Kalra India	21	650 2.1×	420 2.1×	82 0.5×	161 0.9×	32 0.3×	46	1.6k
Tove Tuntland United States	25	732 2.4×	482 2.4×	131 0.7×	126 0.7×	29 0.3×	39	1.7k
Philip F. Hughes United States	28	925 3.0×	501 2.5×	204 1.1×	73 0.4×	47 0.5×	76	2.0k

Countries citing papers authored by Daniel Muthas

Since Specialization

Citations

This map shows the geographic impact of Daniel Muthas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Muthas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Muthas more than expected).

Fields of papers citing papers by Daniel Muthas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Muthas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Muthas. The network helps show where Daniel Muthas may publish in the future.

Co-authorship network of co-authors of Daniel Muthas

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Muthas. A scholar is included among the top collaborators of Daniel Muthas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Muthas. Daniel Muthas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corren, Jonathan, Rachel Moate, Adam Williams, et al.. (2025). FRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma. ERJ Open Research. 12(1). 183–2025. 1 indexed citations

Staples, Karl J., B. Angermann, Graham Belfield, et al.. (2025). Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD. Respiratory Research. 26(1). 114–114. 1 indexed citations

Baker, Tina, Paul J. Newcombe, Patrick G. Gavin, et al.. (2024). Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials. Annals of the Rheumatic Diseases. 83(8). 1018–1027. 32 indexed citations

Dosanjh, Davinder, Daniel Muthas, Chris Chamberlain, et al.. (2024). ARTEMISIA: A JAK1 inhibitor mechanistic study to advance molecular understanding and precision medicine in respiratory diseases. PA342–PA342. 1 indexed citations

Jayne, David, Patrick J. Gavin, Erik L. Allman, et al.. (2023). OP0136 METABOLOMIC SERUM PROFILING IDENTIFIES METABOLITES LINKED TO KIDNEY DAMAGE WHICH ARE MODULATED BY ANIFROLUMAB IN A PHASE 2 TRIAL IN LUPUS NEPHRITIS. Annals of the Rheumatic Diseases. 82. 90–90. 2 indexed citations

Dagher, Rania, Paul Fogel, Jingya Wang, et al.. (2022). Proteomic profiling of serum identifies a molecular signature that correlates with clinical outcomes in COPD. PLoS ONE. 17(12). e0277357–e0277357. 3 indexed citations

Bendtsen, Claus, S Peel, Daniel Muthas, et al.. (2021). Evaluation of FOXO1 Target Engagement Using a Single-Cell Microfluidic Platform. Analytical Chemistry. 93(44). 14659–14666. 5 indexed citations

Honkanen, Jarno, Arja Vuorela, Daniel Muthas, et al.. (2020). Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity. Frontiers in Immunology. 11. 468–468. 34 indexed citations

Riise, Rebecca, Lina Odqvist, Johan Mattsson, et al.. (2019). Bleomycin hydrolase regulates the release of chemokines important for inflammation and wound healing by keratinocytes. Scientific Reports. 9(1). 20407–20407. 17 indexed citations

10.

Winkler, Carla, Thomas Hochdörfer, Elisabeth Israelsson, et al.. (2019). Activation of group 2 innate lymphoid cells after allergen challenge in asthmatic patients. Journal of Allergy and Clinical Immunology. 144(1). 61–69.e7. 71 indexed citations

11.

Grant, Claire, Lorna Ewart, Daniel Muthas, et al.. (2016). The value of integrating pre-clinical data to predict nausea and vomiting risk in humans as illustrated by AZD3514, a novel androgen receptor modulator. Toxicology and Applied Pharmacology. 296. 10–18. 2 indexed citations

12.

Garside, Helen, Alison J. Foster, Daniel Muthas, et al.. (2013). Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes. Toxicology in Vitro. 28(2). 171–181. 74 indexed citations

13.

Muthas, Daniel & Scott Boyer. (2013). Exploiting Pharmacological Similarity to Identify Safety Concerns – Listen to What the Data Tells You. Molecular Informatics. 32(1). 37–45. 11 indexed citations

14.

Ericsson, Daniel J., Ulrika Rosenström, Daniel Muthas, et al.. (2013). Novel pseudopeptides incorporating a benzodiazepine-based turn mimetic—targeting Mycobacterium tuberculosis ribonucleotide reductase. Bioorganic & Medicinal Chemistry. 21(7). 1992–2000. 7 indexed citations

15.

Ericsson, Daniel J., et al.. (2010). Identification of small peptides mimicking the R2 C‐terminus of Mycobacterium tuberculosis ribonucleotide reductase. Journal of Peptide Science. 16(3). 159–164. 7 indexed citations

16.

Odell, Luke R., Mikael Nilsson, Johan Gising, et al.. (2009). Functionalized 3-amino-imidazo[1,2-a]pyridines: A novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(16). 4790–4793. 78 indexed citations

17.

Ottosson, Henrik, Kristine Kilså, M.C. Piqueras, et al.. (2007). Scope and Limitations of Baird's Theory on Triplet State Aromaticity: Application to the Tuning of Singlet–Triplet Energy Gaps in Fulvenes. Chemistry - A European Journal. 13(24). 6998–7005. 78 indexed citations

18.

Muthas, Daniel, Yogesh Sabnis, Magnus Lundborg, & Anders Karlén. (2007). Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering. Journal of Molecular Graphics and Modelling. 26(8). 1237–1251. 47 indexed citations

19.

Roos, A.K., Daniel Muthas, Erik Wahlström, et al.. (2007). Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase. Journal of Peptide Science. 13(12). 822–832. 24 indexed citations

20.

Muthas, Daniel, Yogesh Sabnis, Elizabeth Hamelink, et al.. (2005). Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II. Bioorganic & Medicinal Chemistry. 13(18). 5371–5390. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact